Pendulum Therapeutics Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 116

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $11.4M

  • Investors
  • 21

Pendulum Therapeutics General Information

Description

Developer of microbiome interventions and drugs designed to improve healthcare by managing chronic illnesses and tackling type 2 diabetes. The company integrates laboratory science and computational analysis to gain a comprehensive view of each individual's microbiome through targeted probiotics and prebiotics, enabling clinicians to identify specific microbiome markers and interventions to treat diseases.

Contact Information

Formerly Known As
Whole Biome
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • 933 20th Street
  • San Francisco, CA 94107
  • United States
+1 (844) 000-0000

Pendulum Therapeutics Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pendulum Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC (Series C) 20-Feb-2024 $11.4M 00000 00000 Completed Generating Revenue
12. Debt - General 06-May-2022 0000 00000 Completed Generating Revenue
11. Debt - General 28-Feb-2022 0000 00000 Completed Generating Revenue
10. Mezzanine 31-Dec-2021 000 00000 Completed Generating Revenue
9. Later Stage VC (Series C) 01-Apr-2021 0000 00000 00000 Completed Generating Revenue
8. Later Stage VC (Series B) 30-May-2019 0000 000.00 00000 Completed Generating Revenue
7. Later Stage VC 08-Jun-2017 000.00 000.00 000.00 Completed Generating Revenue
6. Early Stage VC (Series A) 26-Jan-2016 000 0000 0000 Completed Startup
5. Grant 01-Jan-2016 $225K $4M Completed Startup
4. Seed Round 15-Dec-2014 $4M $4M 000.00 Completed Startup
To view Pendulum Therapeutics’s complete valuation and funding history, request access »

Pendulum Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series A-2 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 11,797,144 $0.000100 $0.05 $0.68 $0.68 1x $0.68 12.54%
Seed 5,785,203 $0.000100 $0.05 $0.64 $0.64 1x $0.64 6.15%
To view Pendulum Therapeutics’s complete cap table history, request access »

Pendulum Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of microbiome interventions and drugs designed to improve healthcare by managing chronic illnesses and tacklin
Drug Discovery
San Francisco, CA
116 As of 2024
00000
00000 0000-00-00
00000000000 00000

00000

ercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute ir
0000 000000000
Cambridge, MA
00 As of 0000
0000
0000 0000-00-00
00000000000 0000

000000

on ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolo
0000 000000000
Roseville, MN
00 As of 0000
000.00
00000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pendulum Therapeutics Competitors (51)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Rheos Medicines Venture Capital-Backed Cambridge, MA 00 0000 00000000000 0000
Rebiotix Formerly VC-backed Roseville, MN 00 000.00 00000000000
Vedanta Biosciences Venture Capital-Backed Cambridge, MA 000 00000 0000000000 0 00000
Stemina Biomarker Discovery Venture Capital-Backed Madison, WI 00 000.00 00000000000 000.00
Xeno Biosciences Venture Capital-Backed Cambridge, MA 0 000.00 00000000000 000.00
You’re viewing 5 of 51 competitors. Get the full list »

Pendulum Therapeutics Patents

Pendulum Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020412484-A1 Compositions comprising microbes and methods of use and making thereof Pending 23-Dec-2019 0000000000
US-20230050043-A1 Compositions comprising microbes and methods of use and making thereof Pending 23-Dec-2019 0000000000
CA-3162695-A1 Compositions comprising microbes and methods of use and making thereof Pending 23-Dec-2019 0000000000
EP-4081231-A1 Compositions comprising microbes and methods of use and making thereof Pending 23-Dec-2019 0000000000
EP-4081231-A4 Compositions comprising microbes and methods of use and making thereof Pending 23-Dec-2019 A23L33/135 0
To view Pendulum Therapeutics’s complete patent history, request access »

Pendulum Therapeutics Executive Team (11)

Name Title Board Seat Contact Info
Colleen Cutcliffe Ph.D Co-Founder, Chief Executive Officer & Board Member
John Eid Ph.D Co-Founder, Chief Scientific Officer & Board Member
Halle Berry Chief Communications Officer
James Bullard Ph.D Co-Founder
Matthew Murphy JD General Counsel
You’re viewing 5 of 11 executive team members. Get the full list »

Pendulum Therapeutics Board Members (9)

Name Representing Role Since
Adam D'Augelli True Ventures Board Member 000 0000
Colleen Cutcliffe Ph.D Pendulum Therapeutics Co-Founder, Chief Executive Officer & Board Member 000 0000
Craig Sherman Meritech Capital Partners Board Member 000 0000
Heather Mason Self Board Member 000 0000
Hugh Martin Self Interim Chief Business Officer & Chairman 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Pendulum Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pendulum Therapeutics Investors (21)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alumni Ventures Venture Capital Minority 000 0000 000000 0
ATEL Capital Group Growth/Expansion Minority 000 0000 000000 0
bpd partners Family Office Minority 000 0000 000000 0
Ki Tua Fund Venture Capital Minority 000 0000 000000 0
Nutrition Science Solutions Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 21 investors. Get the full list »

Pendulum Therapeutics FAQs

  • When was Pendulum Therapeutics founded?

    Pendulum Therapeutics was founded in 2012.

  • Who is the founder of Pendulum Therapeutics?

    Colleen Cutcliffe Ph.D, John Eid Ph.D, and James Bullard Ph.D are the founders of Pendulum Therapeutics.

  • Who is the CEO of Pendulum Therapeutics?

    Colleen Cutcliffe Ph.D is the CEO of Pendulum Therapeutics.

  • Where is Pendulum Therapeutics headquartered?

    Pendulum Therapeutics is headquartered in San Francisco, CA.

  • What is the size of Pendulum Therapeutics?

    Pendulum Therapeutics has 116 total employees.

  • What industry is Pendulum Therapeutics in?

    Pendulum Therapeutics’s primary industry is Drug Discovery.

  • Is Pendulum Therapeutics a private or public company?

    Pendulum Therapeutics is a Private company.

  • What is the current valuation of Pendulum Therapeutics?

    The current valuation of Pendulum Therapeutics is 00000.

  • What is Pendulum Therapeutics’s current revenue?

    The current revenue for Pendulum Therapeutics is 000000.

  • How much funding has Pendulum Therapeutics raised over time?

    Pendulum Therapeutics has raised $149M.

  • Who are Pendulum Therapeutics’s investors?

    Alumni Ventures, ATEL Capital Group, bpd partners, Ki Tua Fund, and Nutrition Science Solutions are 5 of 21 investors who have invested in Pendulum Therapeutics.

  • Who are Pendulum Therapeutics’s competitors?

    Rheos Medicines, Rebiotix, Vedanta Biosciences, Stemina Biomarker Discovery, and Xeno Biosciences are some of the 51 competitors of Pendulum Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »